By encouraging the ubiquitination and degradation of HER2, Xia Li worked out a design based on the chimeric ubiquitin ligase of CBL to downregulate HER2, which in turn prevented the proliferation of tumor cells (Li et al., 2007). This evidence concerns the gene CBL and neoplasm.